Keri Baum

1.5k total citations
3 papers, 18 citations indexed

About

Keri Baum is a scholar working on Pharmacology, Molecular Medicine and Applied Microbiology and Biotechnology. According to data from OpenAlex, Keri Baum has authored 3 papers receiving a total of 18 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmacology, 2 papers in Molecular Medicine and 2 papers in Applied Microbiology and Biotechnology. Recurrent topics in Keri Baum's work include Antibiotic Resistance in Bacteria (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Antibiotic Use and Resistance (2 papers). Keri Baum is often cited by papers focused on Antibiotic Resistance in Bacteria (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Antibiotic Use and Resistance (2 papers). Keri Baum collaborates with scholars based in United States and Japan. Keri Baum's co-authors include Alina Iovleva, Eric Cober, David van Duin, Henry F. Chambers, Robert A. Bonomo, Vance G. Fowler, Carol Hill, Robin Patel, Yohei Doi and Erica Herc and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Keri Baum

3 papers receiving 18 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keri Baum United States	2	16	10	7	6	5	3	18
Victoria Gavaghan United States	2	17 1.1×	16 1.6×	5 0.7×	11 1.8×	2 0.4×	2	21
Michael M. Petrov Bulgaria	4	28 1.8×	7 0.7×	7 1.0×	12 2.0×	7 1.4×	8	36
Hector Carrero United States	2	17 1.1×	9 0.9×	14 2.0×	5 0.8×	3 0.6×	2	31
Manuel Crespo Casal Spain	2	17 1.1×	11 1.1×	6 0.9×	11 1.8×	2 0.4×	3	30
Lydia Gálvez-Benítez Spain	4	23 1.4×	16 1.6×	11 1.6×	11 1.8×	3 0.6×	8	32
Beata Potręć Poland	2	23 1.4×	28 2.8×	13 1.9×	8 1.3×	3 0.6×	3	42
Jorge Rodríguez-Gómez Spain	2	9 0.6×	3 0.3×	11 1.6×	4 0.7×	2 0.4×	4	16
Marcin Bula United Kingdom	2	21 1.3×	21 2.1×	13 1.9×	12 2.0×		2	26
Erika Correia Estonia	3	15 0.9×	24 2.4×	19 2.7×	4 0.7×		4	35
Michele Fabiano Mariani Italy	2	4 0.3×	3 0.3×	3 0.4×	4 0.7×	8 1.6×	2	18

Countries citing papers authored by Keri Baum

Since Specialization

Citations

This map shows the geographic impact of Keri Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keri Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keri Baum more than expected).

Fields of papers citing papers by Keri Baum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keri Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keri Baum. The network helps show where Keri Baum may publish in the future.

Co-authorship network of co-authors of Keri Baum

This figure shows the co-authorship network connecting the top 25 collaborators of Keri Baum. A scholar is included among the top collaborators of Keri Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keri Baum. Keri Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Galloway-Peña, Jessica, David van Duin, Leila Ledbetter, et al.. (2024). Participant Diversity in United States Randomized Controlled Trials of Antibacterials for Staphylococcus aureus Infections, 2000–2021. Clinical Infectious Diseases. 79(1). 141–147. 2 indexed citations

2.

Iovleva, Alina, Christi L. McElheny, Eric Cober, et al.. (2024). In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals. Antimicrobial Agents and Chemotherapy. 68(3). e0125823–e0125823. 15 indexed citations

3.

Weston, Gregory, Lauren Komarow, Lizhao Ge, et al.. (2024). Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales. Journal of Antimicrobial Chemotherapy. 79(8). 1929–1937. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact